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Perspectives
I
n a study in this issue of PLoS
Medicine, Pieter van Baal and 
colleagues used data from The 
Netherlands to simulate the annual and 
lifetime medical costs attributable to 
obesity [1]. They also compared these 
costs to those attributable to smoking as 
well as to the medical costs associated 
with healthy, living persons (deﬁned 
as non-smokers with a body mass index 
in the range of 18.5 to less than 25 
kg/m2). The researchers explored the 
question of whether reducing obesity 
would lead to reduced or increased 
health-care costs 
The Main Findings
The study found that although annual 
health-care costs are highest for obese 
people earlier in life (until age 56 
years), and are highest for smokers 
at older ages, the ultimate lifetime 
costs are highest for the healthy 
(nonsmoking, nonobese) people. 
Hence the authors argue that medical 
costs will not be saved by preventing 
obesity.
Their results tell us that that life 
expectancy from age 20 is reduced 
by 5 years for obese people and 7 for 
smokers. The consequence is that 
healthy people live to incur greater 
medical expenditure subsequently on 
average, more than compensating for 
the earlier excess expenditure related 
to obesity or smoking.
The recent Foresight report on 
obesity in the United Kingdom looks 
ahead to 2050 and stresses that obesity 
rates are rising, that the determinants 
of these rises are complex and go much 
further than individual control of 
diet and exercise, and that if nothing 
changes costs to the health service 
and society will increase as a direct 
consequence [2]. Yet van Baal and 
colleagues’ study suggests that obese 
people cost less to health services than 
nonobese people. Smokers cost still 
less. Clearly at a time when obesity is 
deemed a major health issue, in part 
because of its putative health-care costs, 
the results of this new study sound 
paradoxical.
How Should We Interpret These 
Results?
In a sense, Van Baal and colleagues’ 
study is a useful antidote to current 
concerns. But let us be clear: it does 
not attenuate them. Obese people cost 
less because individuals die younger 
and hence with less chronic morbidity 
associated with old age. This is a useful 
thing to know, but how might it affect 
public health strategies for obesity? In 
particular, does it mean that concerns 
about increasing population obesity 
are misplaced, as least as far as health-
service costs are concerned?
Sadly not. Examine an obese 
population and a lean population 
of the same age and sex distribution, 
and the former will incur far greater 
health-care costs throughout the life 
course. Much more diabetes, and more 
cardiovascular disease and cancer 
will occur amongst the obese—even 
amongst the older obese [3]. Compare 
health-care costs now with those thirty 
years ago, and—holding everything 
but obesity constant—the current 
population costs much more to the 
health sector than it did then [4]. 
Moreover, quite apart from health-care 
costs, the other costs to society from 
obesity are also greater because of 
absences from work due to illness and 
employment difﬁculties; these costs 
amount to considerably more than 
health-care costs [5]. It is not clear 
that these extra costs are intrinsically 
related to health-care costs, but they 
are currently estimated to be around 
four times as great in obese than in 
lean people [5].
But is it worth knowing that obese 
individuals are cheaper than lean 
ones for the health sector in the long
run? What does that mean for clinical 
or public health practice? Unless 
taxpayers take their cue and eat too 
much and exercise too little in order 
to reduce their tax burden, it has 
no particular implications. And the 
study may reinforce the cynical view 
that governments may be reluctant 
to intervene when doing so implies 
greater health expenditure on each 
individual through their life. We 
have to be clear, therefore, about the 
distinction between lower lifetime 
health costs associated with obese 
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Linked Research Article
This Perspective discusses the 
following new study published in PLoS
Medicine:
van Baal PHM, Polder JJ, de Wit GA, 
Hoogenveen RT, Feenstra TL, et al. 
(2008) Lifetime medical costs of obesity: 
Prevention no cure for increasing 
health expenditure. PLoS Med 5(2): e29. 
doi:10.1371/journal.pmed.0050029
Using a simulation model, Pieter 
van Baal and colleagues conclude that 
obesity prevention leads to a decrease in 
costs of obesity-related diseases, but this 
is offset by cost increases due to diseases 
unrelated to obesity in life-years gained. PLoS Medicine  |  www.plosmedicine.org 0184 February 2008  |  Volume 5  |  Issue 2  |  e37
individuals and higher costs of obese 
populations.
Quality-Adjusted Life Years
Most people want to live a longer 
life, and they do not consider the 
consequences to society. But a major 
goal of life is to maximise one’s total 
quality-adjusted life years (QALYs). 
Unfortunately, this new study provides 
little insight into the total QALYs 
associated with obesity and smoking. 
Certainly those who are obese and 
those who smoke will live fewer years 
on average, but will these people be 
compensated by enriched quality of 
their fewer years? Available evidence 
suggests strongly that quality of life, 
quite apart from increased illness rates, 
is considerably compromised by obesity 
[6].
We know already that health 
expenditure is high amongst the 
elderly, especially so amongst those 
who die of old age [7]. Van Baal and 
colleagues’ study conﬁrms the high 
medical costs of living to old age, but 
the results should not be interpreted 
as justifying the “cost savings” to 
society of dying younger. And, as the 
authors point out, it would be wrong 
to interpret the ﬁndings as meaning 
that public-health prevention (e.g., 
to prevent obesity) has no beneﬁts. 
As the authors say, whilst prevention 
may not be “a cure for increasing 
expenditures—instead it may well be a 
cost-effective cure for much morbidity 
and mortality and, importantly, 
contribute to the health of nations” [1].
The balance of QALYs gained or lost, 
although not addressed in the van Baal 
study, could have been addressed—at 
least approximately. The subsequent 
analyses ought to tell us what this 
balance looks like for successful 
projects to contain the growth of 
obesity in populations. We need to 
know this balance both for lifetime 
gains and losses in quality of life and 
for comparisons of aggregated quality 
of life between more-obese societies 
and less-obese ones. Unlike the health 
expenditure comparison considered by 
van Baal and colleagues, the signs are 
that the overall balance will be entirely 
positive for obesity prevention—for 
individuals and populations.
Conclusion
Much research is still needed, in the 
United Kingdom at least, on the costs 
of being overweight (BMI >25) as 
opposed to being obese (BMI >30) for 
both the health sector and society as a 
whole. But van Baal and colleagues have 
enhanced our understanding of these 
issues. Translating individual costs and 
beneﬁts to societal costs and beneﬁts is 
never straightforward, and their study 
successfully emphasises the problem. 
People tend to have views about 
health that relate to their individual 
experiences, including personal lifetime 
expenditures. This new study serves to 
remind us that merely multiplying such 
estimates by population sizes of several 
million does not illuminate real public-
health dilemmas. And this kind of 
simpliﬁcation leaves out the numerous 
societal implications of obesity, which 
themselves are massively complex [9]. 
Governments need to understand that 
public-health policies affect more than 
merely the sum of individual health, 
and sadly require greater courage to 
implement than does treating the sick.  
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